Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

pharmaphorum publishingpharmaphorum publishing
VS
Glenmark PharmaceuticalsGlenmark Pharmaceuticals
pharmaphorum publishing

pharmaphorum publishing

Rosemount Avenue, West Byfleet, KT14 6LB, GB

Last Update: 01/01/2026

View Profile
Between 750 and 799
https://pharmaphorum.com/
753/1000Fair

pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. We deliver daily content and multimedia (e.g. video, webinars and podcasts) spanning every aspect of he...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 29/04/2026

View Profile
639/1000Poor

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,777
Subsidiaries:0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
pharmaphorum publishing

pharmaphorum publishing

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for pharmaphorum publishing in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 3.85% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - pharmaphorum publishing (X = Date, Y = Severity)

pharmaphorum publishing cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
pharmaphorum publishing

pharmaphorum publishing

Incidents
No explicit notable incidents reported.
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Incidents
🔒 Incident : Ransomware
KOPGLE1777473227

FAQ

Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?
Between pharmaphorum publishing company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?
Between pharmaphorum publishing and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between pharmaphorum publishing and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - pharmaphorum publishing or Glenmark Pharmaceuticals ?
Which company is PCI DSS compliant - pharmaphorum publishing or Glenmark Pharmaceuticals ?
Between pharmaphorum publishing and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between pharmaphorum publishing and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-63261
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63260
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63259
SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63145
SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63144
SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8